Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Dow Jones International Internet UCITS ETF 04.11.2026 FDNI.LN IE00BT9PVG14  425,002.00 USD   7,294,035.93   17.162  ...
-

Precision BioSciences Announces Pricing of $125 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL) (“Precision”), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced the pricing of an underwritten offering of 10,235,077 shares of its common stock at a price of $7.75 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase up to 5,893,964 shares of its common stock...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 04.11.2026 UIGB IE00079WNSI6   42,493.00 GBP   1,256,620.73   29.572  ...
-

Ironwood Pharmaceuticals Raises Full-Year 2026 Financial Guidance Driven by Continued LINZESS U.S. Net Sales Growth and Strong Third Quarter Financial Performance

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life‑changing therapies for people living with gastrointestinal (GI) and rare diseases, today reported its third quarter 2026 results and recent business performance update. “Ironwood delivered a third consecutive strong quarter as we continue focused execution of our three strategic priorities: maximize LINZESS, advance apraglutide and deliver sustained profits and cas...
-

Versigent CFO to Participate in RBC Capital Markets Global Industrials Conference on November 17

SCHAFFHAUSEN, Switzerland--(BUSINESS WIRE)--Versigent PLC (NYSE: VGNT), a global leader in the design and manufacture of low- and high-voltage electrical architectures, today announced Chief Financial Officer, Doug Ostermann, will participate in a fireside chat at the RBC Capital Markets Global Industrials Conference on Tuesday, November 17, 2026 at 10:40 a.m. ET. The live webcast will be available at the following link: https://kvgo.com/2026-global-Industrials-conference/versigent-plc-november...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 04.11.2026 UNCU.LN IE00BD6GCF16 1,069,907.00 USD  56,611,837.43   52.913  ...
-

Vistance Networks Announces CEO Succession Plan

RICHARDSON, Texas--(BUSINESS WIRE)--Vistance Networks, Inc. (NASDAQ: VISN) today announced Chuck Treadway will step down as President and CEO of the Company on February 1, 2027....
-

Peptilogics Enrolls First International Patient in Phase 2/3 RETAIN Trial of Zaloganan for Treatment of Prosthetic Joint Infection

PITTSBURGH & LEEDS, United Kingdom--(BUSINESS WIRE)--Peptilogics, a clinical stage biotech company dedicated to curing and preventing medical device-related infections (MDRI), today announced that the first patient has been enrolled in the U.K. at Leeds Teaching Hospitals NHS Trust and NIHR Clinical Research Facility: Leeds, in the pivotal RETAIN Phase 2/3 trial of zaloganan (PLG0206) for treatment of prosthetic joint infection (PJI). Led by Investigators Dr. Hemant Pandit, Professor of Orthopa...
-

Aurora Cannabis Announces Fiscal 2027 Second Quarter Results

EDMONTON, Alberta--(BUSINESS WIRE)--Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ | TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the second quarter 2027 ending September 30, 2026. Aurora has cancelled its investor call, originally scheduled for November 12, 2026, at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time, due to the Company’s announcement on November 3, 2026, that Aurora has entered into a defin...
-

Dunham Wins Asset Management STAR Award and Earns Four Luminaries Finalist Honors

SAN DIEGO--(BUSINESS WIRE)--Dunham & Associates Investment Counsel, Inc. (“Dunham”), a San Diego-based asset management firm with more than 40 years of asset management experience, has been named Boutique Winner in the Marketing Innovation category of the Asset Management STAR Awards North America 2026. The award program was developed by the Investment Management Education Alliance (IMEA) in partnership with FT Live, Ignites and FundFire. Winners were recognized October 19, 2026, at the ina...